DK399288A - Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion - Google Patents

Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion

Info

Publication number
DK399288A
DK399288A DK399288A DK399288A DK399288A DK 399288 A DK399288 A DK 399288A DK 399288 A DK399288 A DK 399288A DK 399288 A DK399288 A DK 399288A DK 399288 A DK399288 A DK 399288A
Authority
DK
Denmark
Prior art keywords
double
immune complexes
monocyty
abnormities
strength
Prior art date
Application number
DK399288A
Other languages
Danish (da)
English (en)
Other versions
DK399288D0 (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK399288D0 publication Critical patent/DK399288D0/da
Publication of DK399288A publication Critical patent/DK399288A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
DK399288A 1987-07-17 1988-07-15 Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion DK399288A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7461687A 1987-07-17 1987-07-17
US12457787A 1987-11-24 1987-11-24

Publications (2)

Publication Number Publication Date
DK399288D0 DK399288D0 (da) 1988-07-15
DK399288A true DK399288A (da) 1989-01-18

Family

ID=26755855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK399288A DK399288A (da) 1987-07-17 1988-07-15 Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion

Country Status (18)

Country Link
EP (1) EP0300680B1 (de)
JP (1) JP2601520B2 (de)
KR (1) KR0131880B1 (de)
CN (1) CN1035050A (de)
AT (1) ATE142500T1 (de)
AU (2) AU1820588A (de)
CA (1) CA1326999C (de)
DE (1) DE3855527T2 (de)
DK (1) DK399288A (de)
ES (1) ES2093607T3 (de)
FI (1) FI883352L (de)
HU (1) HUT47432A (de)
IE (1) IE76914B1 (de)
IL (1) IL86862A (de)
NO (1) NO175023C (de)
NZ (1) NZ225310A (de)
OA (1) OA08890A (de)
PT (1) PT87996B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
WO1990014090A1 (en) * 1989-05-19 1990-11-29 Hem Research, Inc. SHORT THERAPEUTIC dsRNA OF DEFINED STRUCTURE
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
EP0495919B1 (de) * 1989-10-11 1997-01-15 Hem Pharmaceuticals Corp. Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
AU2268892A (en) * 1991-07-16 1993-02-23 Hem Pharmaceuticals Corp. Modulation and diagnosis of cytokine dysfunctions
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO1999049029A1 (en) 1998-03-20 1999-09-30 Benitec Australia Ltd Control of gene expression
EP2314700A1 (de) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Zusammensetzung und Verfahren zur in vivo und in vitro Abschwächung der Genexpression mittels dobbelsträngiger RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (de) 2001-01-31 2004-01-28 Nucleonics, Inc Verwendung von post-transkriptioneller Genabschaltung zur Identifizierung von Nukleinsäuresequenzen die die Funktion einer Zelle beeinflussen
EP1838338A2 (de) * 2004-12-29 2007-10-03 Mannkind Corporation Verfahren zum auslösen, erhalten und manipulieren von immunantworten durch gezielte verabreichung von biologischen response-modifikatoren in lymphoiden organen
HUE047172T2 (hu) * 2015-11-17 2020-04-28 Bioncotech Therapeutics S L Újfajta gyógyszerészeti készítmény, mely egy kétszálú poli-ribonukleotid és egy polialkilén-imin egy komplexét tartalmazó részecskéket tartalmaz
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4140761A (en) * 1977-04-11 1979-02-20 The United States Of America As Represented By The Department Of Health, Education & Welfare Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
KR890001580A (ko) 1989-03-27
FI883352A7 (fi) 1989-01-18
DE3855527D1 (de) 1996-10-17
KR0131880B1 (ko) 1998-04-17
JP2601520B2 (ja) 1997-04-16
IE76914B1 (en) 1997-11-05
EP0300680A3 (de) 1991-06-19
JPS6490126A (en) 1989-04-06
OA08890A (en) 1989-10-31
AU1761195A (en) 1995-06-29
EP0300680B1 (de) 1996-09-11
PT87996B (pt) 1995-03-31
DE3855527T2 (de) 1997-04-03
FI883352L (fi) 1989-01-18
NO882853L (no) 1989-01-18
NZ225310A (en) 1991-05-28
NO882853D0 (no) 1988-06-28
NO175023C (no) 1994-08-17
EP0300680A2 (de) 1989-01-25
CA1326999C (en) 1994-02-15
PT87996A (pt) 1989-06-30
DK399288D0 (da) 1988-07-15
IL86862A0 (en) 1988-11-30
AU1820588A (en) 1989-01-19
IL86862A (en) 1993-05-13
FI883352A0 (fi) 1988-07-14
HUT47432A (en) 1989-03-28
ES2093607T3 (es) 1997-01-01
ATE142500T1 (de) 1996-09-15
CN1035050A (zh) 1989-08-30
IE881894L (en) 1989-01-17
NO175023B (no) 1994-05-09

Similar Documents

Publication Publication Date Title
DK399288A (da) Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69111664D1 (de) Blutpumpe und Apparat für die extracorporale Blutzirkulation.
DK465488A (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
TW217382B (de)
FI880513A0 (fi) Anordning foer foeljande med en patients livsfunktioner.
ITMI931777A0 (it) Nuovi agenti per l'ossigenazione extracorporea del sangue
FI904172A7 (fi) Medicinsk katetergivare.
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.
UA10335A (uk) Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment